€19.25
2.28% day before yesterday
Xetra, Jun 06, 05:36 pm CET
ISIN
DE000A289V03
Symbol
93M1
Sector
Industry

MPH Health Care Stock price

€19.25
-4.75 19.79% 1M
-5.35 21.75% 6M
-3.35 14.82% YTD
-13.55 41.31% 1Y
-11.75 37.90% 5Y
-3.55 15.57% 10Y
+8.19 74.09% 20Y
Xetra, Closing price Fri, Jun 06 2025
-0.45 2.28%
ISIN
DE000A289V03
Symbol
93M1
Sector
Industry

Key metrics

Market capitalization €84.34m
Enterprise Value €91.97m
P/E (TTM) P/E ratio 0.69
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 3,065.78
P/S ratio (TTM) P/S ratio 2,811.44
P/B ratio (TTM) P/B ratio 0.25
Dividend yield 6.23%
Last dividend (FY24) €1.20
Revenue growth (TTM) Revenue growth 0.00%
Revenue (TTM) Revenue €30.00k
EBIT (operating result TTM) EBIT €-1.09m
Free Cash Flow (TTM) Free Cash Flow €-23.99m
Cash position €7.33m
EPS (TTM) EPS €27.91
P/S forward 1.35
EV/Sales forward 1.49
Show more

Is MPH Health Care a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,823 stocks worldwide.

MPH Health Care Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast MPH Health Care:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast MPH Health Care:

Buy
100%

Financial data from MPH Health Care

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
0.03 0.03
0% 0%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 1.10 1.10
6% 6%
3,667%
- Research and Development Expense - -
-
-
-1.07 -1.07
7% 7%
-3,567%
- Depreciation and Amortization 0.02 0.02
0% 0%
67%
EBIT (Operating Income) EBIT -1.09 -1.09
7% 7%
-3,639%
Net Profit 119 119
140% 140%
398,267%

In millions EUR.

Don't miss a Thing! We will send you all news about MPH Health Care directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MPH Health Care Stock News

Company Profile

MPH Health Care AG is an investment company, which engages in the acquisition and development of companies and shares in companies from the healthcare industry. It focuses on the market of patent-free and patent-protected pharmaceuticals. The company was founded on November 11, 2008 and is headquartered in Berlin, Germany.

Head office Germany
CEO Patrick Brenske
Employees 2
Founded 2008
Website www.mph-ag.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today